my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Pharmexa A/S is a leading company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. Pharmexa's proprietary technology platforms are broadly applicable, allowing the company to address critical targets in cancer and chronic disease more
Affitech A/S announced that it has appointed two experienced biotech executives to head its management team. Dr Robert Burns, previously CEO of Celldex Therapeutics Inc., has assumed overall responsibility for Affitech as its new Chief Executive Officer. Dr Alexander Duncan, previously SVP Biophar more
VaxOnco Inc, a Korean company specializing in peptide based vaccines, has acquired Pharmexa-Epimmune (Pharmexa Inc.) by the purchase of all outstanding shares from Pharmexa A/S for €440,000. VaxOnco will thus assume all rights and responsibilities relating to the Pharmexa-Epimmune patent portfolio. more
Pharmexa A/S and Affitech AS announced that they have entered into a conditional agreement to merge the two companies by means of a share for share acquisition by Pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the merger is to transform Pharmexa from a cancer and infectio more
Bavarian Nordic A/S (Bavarian Nordic) is a publicly held bio pharmaceutical company developing and producing vaccines for the treatment and prevention of life-threatening diseases. The company primarily focuses on areas of biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and more
Corporate About Medicago Corporate strategy Management team Board of directors Scientific advisory council Current partnerships Technologies Medicago technologies Vaccines Influenza Pandemic market Why Plants? Tobacco Alfalfa Why Proficia™? Why VLPs? VLPExpress Patents/IP Scientific publications Man more
About Us Technology Board Investors Management News Room Contact Board Hans T. Schambye, MD PhD Chairman of Rose’s Board of Directors. Dr. Schambye previously served as Gastrotech's Chief Executive Officer. Before joining Gastrotech, Dr. Schambye served as Director of Biology and Pharmacology an more
FREE hit counter and Internet traffic statistics from freestats.com COMPANY Business Strategy Team Management Team Scientific Advisors History Financial Grants TECHNOLOGY Technology Overview Ichor Advantages Patents PRODUCT DEVELOPMENT Research Overview Data Summary COLLABORATION NEWS & PUBLICATIONS more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
